This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Taveira-DaSilva AM, Moss J. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clinical Epidemiology. 2015;7: 249–257. doi:10.2147/CLEP.S50780.Search in Google Scholar
Harknett EC, Chang WY, Byrnes S, Johnson J, Lazor R, Cohen MM, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. Quarterly Journal of Medicine. 2011;104(11): 971–979. doi:10.1093/QJMED/HCR116.Search in Google Scholar
Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respiratory Medicine. 2002;96(1): 1–6. doi:10.1053/RMED.2001.1207.Search in Google Scholar
Ryu JH, Moss J, Beck GJ, Lee JC, BrownKK, ChapmanJT, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. American Journal of Respiratory and Critical Care Medicine. 2006;173(1): 105–111. doi:10.1164/RCCM.200409-1298OC.Search in Google Scholar
Johnson SR, Cordier JF, Lazor R, Cottin V, Costabe lU, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. European Respiratory Journal. 2010;35(1): 14–26. doi:10.1183/09031936.00076209.Search in Google Scholar
Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease. Part I. American Journal of Respiratory and Critical Care Medicine. 2015;191(12): 1354–1366. doi:10.1164/rccm.201411-2094CI.Search in Google Scholar
Seaman DM, Meyer CA, Gilman MD, McCormack FX. Diffuse cystic lung disease at high-resolution CT. AJR American Journal of Roentgenology. 2011;196(6): 1305–1311. doi:10.2214/AJR.10.4420.Search in Google Scholar
Xu KF, Xu W, Liu S, Yu J, Tian X, Yang Y, et al. Lymphangioleiomyomatosis. Seminars in Respiratory and Critical Care Medicine. 2020;41(2): 256–268. doi:10.1055/s-0040-1702195.Search in Google Scholar